However, we also argue that using cortical GM tissue as a reference may be potentially biased in PSP cases with concomitant 3/4R AD-type tau pathology, which typically targets the fusiform gyrus in early disease stages [52, 53]. The gene discussed is MAPT; the disease is supranuclear palsy, progressive, 1.